Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma.
Chao MP, Alizadeh AA, Tang C, Myklebust JH, Varghese B, Gill S, Jan M, Cha AC, Chan CK, Tan BT, Park CY, Zhao F, Kohrt HE, Malumbres R, Briones J, Gascoyne RD, Lossos IS, Levy R, Weissman IL, Majeti R.
Chao MP, et al.
Cell. 2010 Sep 3;142(5):699-713. doi: 10.1016/j.cell.2010.07.044.
Cell. 2010.
PMID: 20813259
Free PMC article.